Skip to main content
. 2022 Aug 23;22:268. doi: 10.1186/s12871-022-01812-4

Fig. 6.

Fig. 6

Fentanyl activates ovarian cancer cells via stimulating EGFR and in an opioid receptor-dependent manner. A Western blot of EGFR in SK-OV-3 cells after si-EGFR knockdown. EGFR depletion significantly reverses the effects of fentanyl in increasing proliferation (B) and migration (C) in SK-OV-3 cells. D Western blot of p-EGFR and EGFR in SK-OV-3 cells after in the presence of naloxone and fentanyl alone, or both. The blots were cut prior to hybridization with antibodies during blotting. Naloxone (10 μM) completely reverses the effects of fentanyl in increasing proliferation (E) and migration (F) in SK-OV-3 cells. *, p < 0.01, compared to control